In addition, they plan to offer services for in-utero and in-vitro patients to screen for hereditary diseases before birth.
Swiss-based CRISPR Therapeutics hopes to use genetic engineering to help treat millions of people afflicted with hereditary diseases. They’ve created a platform known as CRISPR/Cas9 to cure ailments through gene therapy. In addition, they plan to offer services for in-utero and in-vitro patients to screen for hereditary diseases before birth.